Editorial
Published on 04 Apr 2023
Editorial: Magnetic resonance imaging applications for the diagnosis of prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1191543
- 947 views
Type at least 3 characters
1,647 articles
Original Research
Published on 03 Apr 2023
Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1108937
- 3,204 views
- 3 citations
Original Research
Published on 03 Apr 2023
Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1115718
- 2,815 views
- 10 citations
Original Research
Published on 30 Mar 2023
Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1131473
- 3,780 views
- 11 citations
Case Report
Published on 30 Mar 2023
Malignant glomus tumor of prostate: A case report
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1121307
- 1,361 views
- 4 citations
Case Report
Published on 30 Mar 2023
Primary squamous cell carcinoma of renal parenchyma: A case report and literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1037156
- 5,154 views
- 3 citations
Review
Published on 29 Mar 2023
Identifying novel biomarkers associated with bladder cancer treatment outcomes
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1114203
- 5,342 views
- 19 citations
Original Research
Published on 29 Mar 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1113246
- 1,837 views
- 5 citations
Original Research
Published on 29 Mar 2023
Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.972558
- 3,184 views
- 9 citations
Original Research
Published on 27 Mar 2023
Risk of malignancy in adrenal tumors in patients with a history of cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1018475
- 4,291 views
- 4 citations
Original Research
Published on 27 Mar 2023
Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1081258
- 1,113 views
Original Research
Published on 24 Mar 2023
Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1102623
- 2,142 views
- 3 citations
Original Research
Published on 24 Mar 2023
Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1096341
- 3,269 views
- 6 citations
Correction
Published on 23 Mar 2023
Corrigendum: The learning curve for robot-assisted radical cystectomy with total intracorporeal urinary diversion based on radical cystectomy pentafecta
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1185908
- 933 views
Original Research
Published on 23 Mar 2023
Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1142022
- 1,458 views
Case Report
Published on 22 Mar 2023
Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1114397
- 972 views